business directories by state locations top states florida   businesses california   businesses texas   businesses new york   businesses pennsylvania   businesses advertisements states alabama  companies found  people found alaska  companies found  people found arizona  companies found  people found arkansas  companies found  people found california  companies found  people found colorado  companies found  people found connecticut  companies found  people found delaware  companies found  people found district of columbia  companies found  people found florida  companies found  people found georgia  companies found  people found hawaii  companies found  people found idaho  companies found  people found illinois  companies found  people found indiana  companies found  people found iowa  companies found  people found kansas  companies found  people found kentucky  companies found  people found louisiana  companies found  people found maine  companies found  people found maryland  companies found  people found massachusetts  companies found  people found michigan  companies found  people found minnesota  companies found  people found mississippi  companies found  people found missouri  companies found  people found montana  companies found  people found nebraska  companies found  people found nevada  companies found  people found new hampshire  companies found  people found new jersey  companies found  people found new mexico  companies found  people found new york  companies found  people found north carolina  companies found  people found north dakota  companies found  people found ohio  companies found  people found oklahoma  companies found  people found oregon  companies found  people found pennsylvania  companies found  people found puerto rico  companies found  people found rhode island  companies found  people found south carolina  companies found  people found south dakota  companies found  people found tennessee  companies found  people found texas  companies found  people found utah  companies found  people found vermont  companies found  people found virginia  companies found  people found washington  companies found  people found west virginia  companies found  people found wisconsin  companies found  people found wyoming  companies found  people found company directory browse directory by company name a b c d e f g h i j k l m n o p q r s t u v w x y z more people directory names starting with letters a b c d e f g h i j k l m n o p q r s t u v w x y z you must be signed in to print once signed in look for the pdf button randall schatzman  alder biopharmaceuticals inc  zoominfocom   randall c schatzman phd executive profile  biography  bloomberg july    pm et biotechnology company overview of alder biopharmaceuticals inc snapshotpeople  overviewboard memberscommittees executive profile randall c schatzman phdcofounder chief executive officer president and director alder biopharmaceuticals incagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background dr randall c schatzman phd cofounded alder biopharmaceuticals inc in may  and has been its chief executive officer and president since may  dr schatzman served as senior vice president of discovery research at celltech rd inc where he led a group of  scientists responsible for much of the therapeutic antibody pipeline for celltech prior to celltech he served as a director of gene discovery at mercator genetics helping to solve the gene responsible  for hereditary hemochromatosis and advancing the del angiogenesis factor into preclinical models and partnering del with valentis prior to mercator he was at syntexroche bioscience where he helped found the cancer and developmental biology institute and served as preclinical team leader for cytovene and team leader for valcyte and was responsible for preclinical studies on cellcept he serves as a member of advisory board of immusoft corporation he has been director of alder biopharmaceuticals inc since january  he received his phd in molecular pharmacology from emory university before completed an american cancer society postdoctoral fellowship in the laboratory of j michael bishop at the university of california san franciscoread full background corporate headquarters  north creek parkway southbothell washington united statesphone fax  board members memberships presentcofounder chief executive officer president and directoralder biopharmaceuticals inc education phd emory universitybs purdue university other affiliations emory universitypurdue universityimmusoft corporation annual compensation salarytotal annual compensation stocks options all other compensationexercised optionsexercised options valueexercisable optionsexercisable options valueunexercisable optionsunexercisable options valuetotal value of optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationthere is no competitor compensation data available sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact alder biopharmaceuticals inc please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close bizapediacom  human validation companiespeopleproductsservicestrademarksaddressesphone book our system has detected a high number of page requests from your ip address please prove to us that you are a human to continue using our website please send me to the search subscription offer page after i successfully answer the word challenge bizapediapro searchperform unlimited searches via ouradvanced search form withbizapedia pro searchfind out more bizapediapro databuild custom data listsfor one or many stateswith bizapedia pro datafind out more  copyright   · bizapediacom · all rights reservedblogpro searchpro apicontact usterms of useprivacy policysitemapdesktop version randall c schatzman phd  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in randall c schatzman phd dir president and chief executive officer at alder biopharmaceuticals inc view full profile are you randall c schatzman phd claim your profile   sign up for equilar atlas and view randall c schatzman phds full profile with equilar atlas you can identify corporate executives in randall c schatzman phds network and community follow changes in randall c schatzman phds employment and moneyinmotion connect with randall c schatzman phd through your network of contacts randall c schatzman phds executive work history current dir president and chief executive officer alder biopharmaceuticals inc past to view randall c schatzman phds complete executive work history sign up now age      randall c schatzman phds biography dr schatzman has served as our president chief executive officer and director since he cofounded the company which commenced operations in january  from  to  dr schatzman served as senior vice president of discovery research at celltech rd inc a whollyowned subsidiary of celltech group plc a biopharmaceutical company where he led a group of scientists responsible for much of the therapeutic antibody pipeline for celltech from  to  dr schatzman served as director of gene discovery at mercator genetics inc a genomics company from  to  dr schatzman served as section leader at roche bioscience pr  read more dr schatzman has served as our president chief executive officer and director since he cofounded the company which commenced operations in january  from  to  dr schatzman served as senior vice president of discovery research at celltech rd inc a whollyowned subsidiary of celltech group plc a biopharmaceutical company where he led a group of scientists responsible for much of the therapeutic antibody pipeline for celltech from  to  dr schatzman served as director of gene discovery at mercator genetics inc a genomics company from  to  dr schatzman served as section leader at roche bioscience previously syntex corp a subsidiary of roche holdings ltd a biotechnology company where he helped found the cancer and developmental biology institute dr schatzman holds a phd in molecular pharmacology from emory university and a bs in biochemistry from purdue university the nominating and corporate governance committee believes that dr schatzman is qualified to serve on our board of directors due to his extensive knowledge of our company and his extensive background in the biotechnology industry source alder biopharmaceuticals inc on    sign up for equilar atlas and view randall c schatzman phds full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like randall c schatzman phd more specifically youll be able to identify corporate executives in randall c schatzman phds network and community follow changes in randall c schatzman phds employment and moneyinmotion connect with randall c schatzman phd through your network of conections view full profile   search for over  executive profiles bio example randall c schatzman phd randall c schatzman phds connections  sign up now to view randall c schatzman phds  connections » clay b siegall president chief executive officer and chairman of the board seattle genetics inc elisabeth a sandoval chief commercial officer alder biopharmaceuticals inc alan b montgomery board member alder biopharmaceuticals inc mark j litton chief business officer treasurer and secretary alder biopharmaceuticals inc deepika r pakianathan former board member alder biopharmaceuticals inc jeffrey t smith senior vice president translational medicine alder biopharmaceuticals inc john a latham chief scientific officer alder biopharmaceuticals inc larry k benedict executive vice president principal accounting officer and principal financial officer alder biopharmaceuticals inc stephen m dow former chairman of the board alder biopharmaceuticals inc timothy m whitaker chief medical officer alder biopharmaceuticals inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   schatzman randall nameagestate randall c schatzman wa find more people first name mi last name state all states alabama alaska arizona arkansas california colorado connecticut delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virginia washington washington dc west virginia wisconsin wyoming i entered a partial first name above phone number search ex  randall schatzman at instantpeoplefindercom find information on randall schatzman instantly help  contact us  faqs  terms  conditions copyright   lookupanyone leadership team  alder biopharmaceuticals leadership team leadership team randall c schatzman phd president and chief executive officer dr schatzman has served as our president chief executive officer and director since he cofounded the company which commenced operations in january  from  to  dr schatzman served as senior vice president of discovery research at celltech rd inc a wholly owned subsidiary of celltech group plc a biopharmaceutical company where he led a group of scientists responsible for much of the therapeutic antibody pipeline for celltech from  to  dr schatzman served as director of gene discovery at mercator genetics inc a genomics company from  to  dr schatzman served as section leader at roche bioscience previously syntex corp a subsidiary of roche holdings ltd a biotechnology company where he helped found the cancer and developmental biology institute dr schatzman holds a phd in molecular pharmacology from emory university and a bs in biochemistry from purdue university john a latham phd chief scientific officer dr latham has served as our chief scientific officer since cofounding alder biopharmaceuticals in january from  to  dr latham served as a director senior director and most recently as vice president of gene function and target validation for celltech group plc in  dr latham joined darwin molecular corporation a firstgeneration genetodrug biotechnology company as a founding director where he served from  to  dr latham was one of the early scientists hired by gilead sciences inc a biopharmaceutical company and from  to  he was a member of a core group established to exploit novel oligonucleotidebased technologies dr latham holds a phd in biochemistry from massachusetts institute of technology and a bs in chemistry from colorado state university mark j litton phd mba chief business officer and treasurer dr litton has served as our chief business officer treasurer and secretary since cofounding the company in january  from  to  dr litton served as vice president of business development for celltech group where he was responsible for securing commercializing and partnering numerous novel discoveries and therapeutic opportunities in  dr litton joined celltech group as an employee of chiroscience group plc and was later promoted to vice president business development after chiroscience’s merger with celltech group in  from  to  dr litton served as the manager of business development for ribozyme pharmaceuticals inc currently sirna therapeutics inc a biopharmaceutical company where he helped form relationships with eli lilly and company roche bioscience and glaxowellcome plc currently glaxosmithkline plc a biopharmaceutical company from  to  dr litton served as a research associate for dnax research institute a research facility of scheringplough now merck  co a publicly traded pharmaceutical company dr litton holds a phd in immunology from stockholm university an mba from santa clara university and a bs in biochemistry from the university of california santa cruz jeffrey tl smith md frcp senior vice president translational medicine dr smith has served as our senior vice president translational medicine since  and served in other senior management positions from april  to from  to  dr smith served as senior director of medical research for celltech rd where he was responsible for planning and managing the cdp antitnf clinical trials for ra as well as several other key autoimmune clinical development programs from  to  dr smith served as medical director at simbec research ltd a contract research organization from  to  dr smith served as head of clinical pharmacology at hoechst marion roussel ltd a pharmaceutical company from  to  dr smith served as a senior clinical physician at the proctor and gamble company a publiclytraded consumer products company and from  to  he served as a senior research physician in the clinical pharmacology department at glaxo research and development ltd now a division of glaxosmithkline plc a healthcare company dr smith holds an md from the university of london and is a fellow of the royal college of physicians in london elisabeth a sandoval mba chief commercial officer ms sandoval has served as our chief commercial officer since september from  to  ms sandoval served as the chief commercial officer for kythera biopharmaceuticals from  to  she served as vice president of global marketing and strategy at bausch  lomb surgical from  to  she held roles of increasing responsibility at allergan including global vice president strategic marketing and senior director of global strategic marketing which included sales management and marketing leadership for multiple products including botox® for neurological and other disorders she began her career in research and development at johnson  johnson’s ethicon division she holds an mba from pepperdine university and a bs in biology from the university of california irvine timothy m whitaker md chief medical officer dr whitaker has served as our chief medical officer since june from  to  dr whitaker held positions of increasing responsibility at shire plc most recently as the vice president and neuroscience therapeutic area head of global clinical development from  to  dr whitaker held the positions of associate director director and senior director of clinical research and development for the neuroscience divisions at wyeth pharmaceuticals from  to  he held a variety of teaching and clinical appointments at the university of vermont college of medicine and the medical center hospital of vermont including associate professor of psychiatry and director of the psychopharmacology clinic he holds an md from wake forest university school of medicine in winstonsalem nc and a ba from duke university larry benedict executive vice president and principal accounting officer mr benedict joined alder in  and has served as our executive vice president and principal accounting officer since october since joining alder mr benedict has held increasing financial leadership roles including vice president of finance and most recently senior vice president of finance from  to  mr benedict served in various positions at seattle genetics inc a publicly traded biotechnology company most recently as director of finance and controller from  to  mr benedict served as chief financial officer at sensible solutions inc a financial software consulting company from  to  mr benedict served as finance manager at smithkline beecham clinical laboratories now quest diagnostics incorporated from  to  he held various finance roles at bristolmyers squibb company a biopharmaceutical company mr benedict holds a bs in accounting from central washington university nancy l boman md phd senior vice president of regulatory affairs and pharmacovigilance dr boman has served as our senior vice president of regulatory affairs and pharmacovigilance since september from  to  dr boman served as the senior vice president of clinical development and regulatory affairs at cti biopharma a biopharmaceutical company focused on novel targeted therapies for bloodrelated cancers she had previously held the positions of vice president of clinical development and regulatory affairs at cti biopharma and vice president of clinical development and regulatory affairs at acucela dr boman previously held senior clinical development and regulatory affairs positions at genentech amgen and qlt dr boman holds a phd in biochemistry an md and a bs from the university of british columbia in vancouver james b bucher jd senior vice president and general counsel mr bucher has served as our senior vice president and general counsel since january prior to joining alder biopharmaceuticals mr bucher served as vice president corporate legal affairs and secretary and as the corporate compliance officer of exelixis inc a nasdaqlisted biopharmaceutical company which he joined in  from  to  mr bucher practiced as a corporate attorney at the international law firm shearman  sterling llp becoming a partner in  mr bucher holds a jd with distinction from emory university school of law and a ba in biology from colgate university randy hassler  senior vice president pharmaceutical operations mr hassler has served as our senior vice president of pharmaceutical operations since august prior to joining alder biopharmaceuticals mr hassler served as vice president of operations and finance and chief operating officer for seven years at seattle biomedical research institute working on the fight against global infectious diseases from  to  he served in various leadership positions at amgen including process development quality control and quality assurance in addition he also played major roles in amgen’s acquisitions of both immunex and abgenix from  to  mr hassler served in a variety of research and development positions at synergen in boulder colorado mr hassler holds a bs in microbiology from indiana university and an ms in microbiology from colorado state university annette vahratian senior vice president quality ms vahratian has served as our senior vice president of quality since  prior to joining alder as vice president quality in  ms vahratian served as principal quality consultant for ten years at av biopharma consulting serving the greater biopharmaceutical industry in support of innovator biologics drug development and regulatory product registrations while at immunex corporation now amgen from  to  ms vahratian served as vp quality and various management positions where she was instrumental in gaining fda approval of enbrel® and managing enbrel® commercial operations at multiple sites worldwide ms vahratian supported wyeth now pfizer in their international registration of enbrel® in the european union ms vahratian has been involved in more than  ind applications and two fda marketing authorization drug approvals ms vahratian holds a bs in biology and psychology from hope college overview mission leadership team board of directors scientific advisors history   menu about us overview mission leadership team board of directors scientific advisors history research and development pipeline technologies clinical trials media in the news press releases investors investors press releases events  presentations financials  filings corporate governance stock information analyst coverage investor faqs shareholder briefcase email alerts subscription contact us careers careers current openings contact × aldr randall c schatzman insider trades for alder biopharmaceuticals inc bulletin investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close alder biopharmaceuticals inc nasdaq aldr go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus alder biopharmaceuticals inc market open  real time quotes jul    pm aldr quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual randall c schatzman dr randall c schatzman is president chief executive officer  director at alder biopharmaceuticals inc and a manager at alderbio holdings llc he is on the board of directors at alder biopharmaceuticals inc dr schatzman was previously employed as a directorgene discovery by mercator genetics inc a principal by syntex inc and senior vice presidentdiscovery research by celltech rd inc he received his undergraduate degree from purdue university and a doctorate degree from emory university transactions date shares transaction value     disposition at  per share      derivativenonderivative trans at  per share      award at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      derivativenonderivative trans at  per share      disposition at  per share      disposition at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives dr randall c schatzman president chief executive officer  director dr timothy whitaker chief medical officer dr john a latham chief scientific officer mr annette vahratian senior vice presidentquality dr nancy l boman senior vice presidentregulatory affairs ms elisabeth a sandoval chief commercial officer mr david a walsey investor relations contact dr jeffrey t l smith senior vice presidenttranslational medicine ms wendy l yarno director mr paul r carter director mr paul b cleveland director dr mark j litton secretary treasurer  chief business officer mr larry benedict chief accounting officer  executive vp mr james b bucher senior vice president  general counsel mr stephen m dow chairman dr clay b siegall independent director dr alan b montgomery independent director dr deepa r pakianathan independent director dr heather elizabeth preston independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest p things to do in london for  or less pwho are the beneficiaries of a k if my wife and i die at the same time pcharlie gard british baby at center of controversy has died punder armours stocks low price doesnt mean it is cheap pretirement weekly news and analysis pfloyd mayweather says he is going to make bank off an ico pfoxconn’s history of broken promises casts a shadow on wisconsin news pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ pthis city’s subway system will soon run mostly on renewable energy pwhich state’s  plan is right for you pwhy so many teens are clueless about money phere’s something that can improve your memory — and help you sleep pgold marks highest finish since midjune up  for the week phow your pet could make you a target for scammers poil sets sights on biggest weekly gain of the year paugust gold climbs  or  to settle at oz pgold prices log highest finish since midjune up  for the week pstitch fix has confidentially filed to go public report pcan china make the reflation trade great again pget ready for the lessprofitable amazon that you used to know loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  leadership team  alder biopharmaceuticals leadership team leadership team randall c schatzman phd president and chief executive officer dr schatzman has served as our president chief executive officer and director since he cofounded the company which commenced operations in january  from  to  dr schatzman served as senior vice president of discovery research at celltech rd inc a wholly owned subsidiary of celltech group plc a biopharmaceutical company where he led a group of scientists responsible for much of the therapeutic antibody pipeline for celltech from  to  dr schatzman served as director of gene discovery at mercator genetics inc a genomics company from  to  dr schatzman served as section leader at roche bioscience previously syntex corp a subsidiary of roche holdings ltd a biotechnology company where he helped found the cancer and developmental biology institute dr schatzman holds a phd in molecular pharmacology from emory university and a bs in biochemistry from purdue university john a latham phd chief scientific officer dr latham has served as our chief scientific officer since cofounding alder biopharmaceuticals in january from  to  dr latham served as a director senior director and most recently as vice president of gene function and target validation for celltech group plc in  dr latham joined darwin molecular corporation a firstgeneration genetodrug biotechnology company as a founding director where he served from  to  dr latham was one of the early scientists hired by gilead sciences inc a biopharmaceutical company and from  to  he was a member of a core group established to exploit novel oligonucleotidebased technologies dr latham holds a phd in biochemistry from massachusetts institute of technology and a bs in chemistry from colorado state university mark j litton phd mba chief business officer and treasurer dr litton has served as our chief business officer treasurer and secretary since cofounding the company in january  from  to  dr litton served as vice president of business development for celltech group where he was responsible for securing commercializing and partnering numerous novel discoveries and therapeutic opportunities in  dr litton joined celltech group as an employee of chiroscience group plc and was later promoted to vice president business development after chiroscience’s merger with celltech group in  from  to  dr litton served as the manager of business development for ribozyme pharmaceuticals inc currently sirna therapeutics inc a biopharmaceutical company where he helped form relationships with eli lilly and company roche bioscience and glaxowellcome plc currently glaxosmithkline plc a biopharmaceutical company from  to  dr litton served as a research associate for dnax research institute a research facility of scheringplough now merck  co a publicly traded pharmaceutical company dr litton holds a phd in immunology from stockholm university an mba from santa clara university and a bs in biochemistry from the university of california santa cruz jeffrey tl smith md frcp senior vice president translational medicine dr smith has served as our senior vice president translational medicine since  and served in other senior management positions from april  to from  to  dr smith served as senior director of medical research for celltech rd where he was responsible for planning and managing the cdp antitnf clinical trials for ra as well as several other key autoimmune clinical development programs from  to  dr smith served as medical director at simbec research ltd a contract research organization from  to  dr smith served as head of clinical pharmacology at hoechst marion roussel ltd a pharmaceutical company from  to  dr smith served as a senior clinical physician at the proctor and gamble company a publiclytraded consumer products company and from  to  he served as a senior research physician in the clinical pharmacology department at glaxo research and development ltd now a division of glaxosmithkline plc a healthcare company dr smith holds an md from the university of london and is a fellow of the royal college of physicians in london elisabeth a sandoval mba chief commercial officer ms sandoval has served as our chief commercial officer since september from  to  ms sandoval served as the chief commercial officer for kythera biopharmaceuticals from  to  she served as vice president of global marketing and strategy at bausch  lomb surgical from  to  she held roles of increasing responsibility at allergan including global vice president strategic marketing and senior director of global strategic marketing which included sales management and marketing leadership for multiple products including botox® for neurological and other disorders she began her career in research and development at johnson  johnson’s ethicon division she holds an mba from pepperdine university and a bs in biology from the university of california irvine timothy m whitaker md chief medical officer dr whitaker has served as our chief medical officer since june from  to  dr whitaker held positions of increasing responsibility at shire plc most recently as the vice president and neuroscience therapeutic area head of global clinical development from  to  dr whitaker held the positions of associate director director and senior director of clinical research and development for the neuroscience divisions at wyeth pharmaceuticals from  to  he held a variety of teaching and clinical appointments at the university of vermont college of medicine and the medical center hospital of vermont including associate professor of psychiatry and director of the psychopharmacology clinic he holds an md from wake forest university school of medicine in winstonsalem nc and a ba from duke university larry benedict executive vice president and principal accounting officer mr benedict joined alder in  and has served as our executive vice president and principal accounting officer since october since joining alder mr benedict has held increasing financial leadership roles including vice president of finance and most recently senior vice president of finance from  to  mr benedict served in various positions at seattle genetics inc a publicly traded biotechnology company most recently as director of finance and controller from  to  mr benedict served as chief financial officer at sensible solutions inc a financial software consulting company from  to  mr benedict served as finance manager at smithkline beecham clinical laboratories now quest diagnostics incorporated from  to  he held various finance roles at bristolmyers squibb company a biopharmaceutical company mr benedict holds a bs in accounting from central washington university nancy l boman md phd senior vice president of regulatory affairs and pharmacovigilance dr boman has served as our senior vice president of regulatory affairs and pharmacovigilance since september from  to  dr boman served as the senior vice president of clinical development and regulatory affairs at cti biopharma a biopharmaceutical company focused on novel targeted therapies for bloodrelated cancers she had previously held the positions of vice president of clinical development and regulatory affairs at cti biopharma and vice president of clinical development and regulatory affairs at acucela dr boman previously held senior clinical development and regulatory affairs positions at genentech amgen and qlt dr boman holds a phd in biochemistry an md and a bs from the university of british columbia in vancouver james b bucher jd senior vice president and general counsel mr bucher has served as our senior vice president and general counsel since january prior to joining alder biopharmaceuticals mr bucher served as vice president corporate legal affairs and secretary and as the corporate compliance officer of exelixis inc a nasdaqlisted biopharmaceutical company which he joined in  from  to  mr bucher practiced as a corporate attorney at the international law firm shearman  sterling llp becoming a partner in  mr bucher holds a jd with distinction from emory university school of law and a ba in biology from colgate university randy hassler  senior vice president pharmaceutical operations mr hassler has served as our senior vice president of pharmaceutical operations since august prior to joining alder biopharmaceuticals mr hassler served as vice president of operations and finance and chief operating officer for seven years at seattle biomedical research institute working on the fight against global infectious diseases from  to  he served in various leadership positions at amgen including process development quality control and quality assurance in addition he also played major roles in amgen’s acquisitions of both immunex and abgenix from  to  mr hassler served in a variety of research and development positions at synergen in boulder colorado mr hassler holds a bs in microbiology from indiana university and an ms in microbiology from colorado state university annette vahratian senior vice president quality ms vahratian has served as our senior vice president of quality since  prior to joining alder as vice president quality in  ms vahratian served as principal quality consultant for ten years at av biopharma consulting serving the greater biopharmaceutical industry in support of innovator biologics drug development and regulatory product registrations while at immunex corporation now amgen from  to  ms vahratian served as vp quality and various management positions where she was instrumental in gaining fda approval of enbrel® and managing enbrel® commercial operations at multiple sites worldwide ms vahratian supported wyeth now pfizer in their international registration of enbrel® in the european union ms vahratian has been involved in more than  ind applications and two fda marketing authorization drug approvals ms vahratian holds a bs in biology and psychology from hope college overview mission leadership team board of directors scientific advisors history   menu about us overview mission leadership team board of directors scientific advisors history research and development pipeline technologies clinical trials media in the news press releases investors investors press releases events  presentations financials  filings corporate governance stock information analyst coverage investor faqs shareholder briefcase email alerts subscription contact us careers careers current openings contact × microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft